Home › NDC Lookup › RxCUI directory › RxCUI 848730

Iloperidone 10 MG Oral Tablet [Fanapt] — RxCUI 848730

RxNorm drug concept · Semantic branded drug
RxCUI 848730 Semantic branded drug · SBD ● Current RxNorm concept 17 FDA products 17 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI848730
Official nameIloperidone 10 MG Oral Tablet [Fanapt]
Concept typeSemantic branded drug (SBD)
RxNorm statusCurrent RxNorm concept
Also known asFanapt 10 MG Oral Tablet
FDA products mapped17
Package NDCs mapped17
Reported Medicaid activity (SDUD)31,677 prescriptions · 38 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Iloperidone: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • Iloperidone tablets are approved to treat schizophrenia in adults. If you've been prescribed the brand Fanapt, it has one additional approved use: treating acute manic or mixed epi...
  • Iloperidone can cause a significant drop in blood pressure when you first start it — especially when you stand up quickly — which can make you dizzy or even faint. That's called or...
  • Why do I have to start on such a small dose and increase it slowly?
  • The most common side effects include dizziness (especially when standing), drowsiness, dry mouth, a fast heartbeat, nasal congestion, fatigue, and some weight gain. Most of these e...
📖 Read our full Iloperidone guide →

🕸️ Concept Web — How Iloperidone 10 MG Oral Tablet [Fanapt] Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept Iloperidone 10 MG Oral Tablet [Fanapt] RxCUI 848730

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 1

    The active substance itself — no strength, form, or brand attached yet.

    • Iloperidone 73178
  2. Brand names 1

    The same medicine's trade names. A brand name alone says nothing about strength or form.

    • Fanapt 848723
  3. Dose forms 9

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Iloperidone Oral Tablet 848721
    • Iloperidone Oral Product 1160677
    • Iloperidone Pill 1160678
    • Iloperidone Oral Tablet [Fanapt] 848725
    • Fanapt Oral Product 1174678
    • Fanapt Pill 1174679
    • Oral Tablet 317541
    • Oral Product 1151131
    • +1 more in this family
  4. Clinical & branded drugs 3

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

Showing up to 8 concepts per family — 13 of 14 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Iloperidone 10 MG Oral Tablet SCD · 848728
  • Iloperidone 10 MG SCDC · 848727
  • Iloperidone Oral Tablet SCDF · 848721
  • Iloperidone Oral Product SCDG · 1160677
  • Iloperidone Pill SCDG · 1160678

Brand-Name Concepts

  • Iloperidone 10 MG [Fanapt] SBDC · 848729
  • Iloperidone Oral Tablet [Fanapt] SBDF · 848725
  • Fanapt Oral Product SBDG · 1174678
  • Fanapt Pill SBDG · 1174679
  • Fanapt BN · 848723

📦 FDA Products & Package NDCs

17 products · 17 package NDCs
17 package NDCs map to RxCUI 848730 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
43068-0101-02 60 TABLET in 1 BOTTLE (43068-101-02) FANAPT Vanda Pharmaceuticals Inc. 2016-05-01
43068-0102-02 60 TABLET in 1 BOTTLE (43068-102-02) FANAPT Vanda Pharmaceuticals Inc. 2016-08-01
43068-0104-02 60 TABLET in 1 BOTTLE (43068-104-02) FANAPT Vanda Pharmaceuticals Inc. 2015-12-15
43068-0106-02 60 TABLET in 1 BOTTLE (43068-106-02) FANAPT Vanda Pharmaceuticals Inc. 2016-07-01
43068-0108-02 60 TABLET in 1 BOTTLE (43068-108-02) FANAPT Vanda Pharmaceuticals Inc. 2015-09-15
43068-0110-02 60 TABLET in 1 BOTTLE (43068-110-02) FANAPT Vanda Pharmaceuticals Inc. 2016-01-15
43068-0112-02 60 TABLET in 1 BOTTLE (43068-112-02) FANAPT Vanda Pharmaceuticals Inc. 2016-10-15
43068-0113-04 1 BLISTER PACK in 1 DOSE PACK (43068-113-04) / 1 KIT in 1 B... FANAPT Vanda Pharmaceuticals Inc. 2015-12-01
43068-0114-03 1 BLISTER PACK in 1 DOSE PACK (43068-114-03) / 1 KIT in 1 B... FANAPT Vanda Pharmaceuticals Inc. 2025-05-01
43068-0115-04 1 BLISTER PACK in 1 DOSE PACK (43068-115-04) / 1 KIT in 1 B... FANAPT Vanda Pharmaceuticals Inc. 2025-08-01
43068-0901-14 14 TABLET in 1 BOTTLE (43068-901-14) FANAPT Vanda Pharmaceuticals Inc. 2018-09-24
43068-0902-14 14 TABLET in 1 BOTTLE (43068-902-14) FANAPT Vanda Pharmaceuticals Inc. 2018-09-24
43068-0903-08 1 BLISTER PACK in 1 DOSE PACK (43068-903-08) / 1 KIT in 1 B... FANAPT Vanda Pharmaceuticals Inc. 2018-09-24
43068-0904-14 14 TABLET in 1 BOTTLE (43068-904-14) FANAPT Vanda Pharmaceuticals Inc. 2024-06-11
43068-0905-14 14 TABLET in 1 BOTTLE (43068-905-14) FANAPT Vanda Pharmaceuticals Inc. 2024-06-11
43068-0906-08 1 BLISTER PACK in 1 DOSE PACK (43068-906-08) / 1 KIT in 1 B... FANAPT Vanda Pharmaceuticals Inc. 2025-05-01
43068-0907-12 1 BLISTER PACK in 1 DOSE PACK (43068-907-12) / 1 KIT in 1 B... FANAPT Vanda Pharmaceuticals Inc. 2025-08-01
Observed labelers: Vanda Pharmaceuticals Inc. (17) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.